Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2023, Vol. 11 Issue (3): 168-173    DOI: 10.3969/j.issn.2095-5340.2023.03.002
  生殖胚胎   论著 |
卵胞浆内单精子显微注射治疗周期中促性腺激素用药对胚胎发育潜能的影响
胡婷婷 汪伟伟 胡益祥 张颖 蔡艳萍 颜宏利
1. 同济大学附属第四人民医院 检验科,上海 200081;2. 海军军医大学第一附属医院 生殖医学中心,上海 200433;3. 上海交通大学附属瑞金医院 转化医学中心,上海 200001
Effect of gonadotropin administration on embryonic developmental potential during intracytoplasmic sperm microinjection
Hu Tingting, Wang Weiwei, Hu Yixiang, et al
1. Department of Clinical Laboratory, the Fourth People's Hospital of Tongji University, Shanghai 200081, China; 2.Reproductive Medicine Center, the First Affiliated Hospital of Navy Medical University, ShangHai 200433, China; 3. Translational Medicine Center, Ruijin Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200001, China
下载:  PDF (967KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 【摘要】 目的  探讨卵胞浆内单精子显微注射(intracytoplasmic sperm injection,ICSI)第3 天新鲜移植
周期中,促性腺激素(gonadotropin,Gn)用药天数及Gn 总量与胚胎发育潜能的相关性,以及胚胎发育速
度对妊娠结局的影响。 方法 回顾性分析2017 年1 月1 日至2020 年12 月31 日,在海军军医大学第
一附属医院行ICSI 助孕,并于胚胎发育第3 天接受体外受精- 胚胎移植(in vitro fertilization - embryo
transfer,IVF-ET)的患者,共纳入299 个周期。按照卵裂球数目的不同分为8 细胞(8C)+7 细胞(7C)组、8C+8C 组、8C+9 细胞(9C)组、8C+ 早期融合组(包括部分融合期胚胎和融合期胚胎)。以取卵日为第 0 天(D0),第3 天(D3)上午即受精后67~69 h 观察胚胎卵裂情况,移植2 枚胚胎。记录女方的年龄、体质量指数(body mass index,BMI)、基础促卵泡刺激素(follicle-stimulating hormone,FSH)、不孕年限、Gn 用药天数、Gn 用量、周期获卵数、移植胚胎数、种植率、临床妊娠率、流产率和活产率。统计学方 法采用单因素方差分析和χ2 检验。 结果  各组间的女方年龄、BMI、不孕年限、基础FSH 比较,
差异无统计学意义(P 值均>0.05)。8C+7C 组、8C+8C 组、8C+9C 组、8C+ 融合组的Gn 用药天数分
别为(10.9±2.8)、(10.3±2.2)、(10.7±2.3)、(8.5±2.2)d,Gn 用量分别为(2 172±615)、(2 167±673)、(2 332±796)、(1 779±719)IU ;8C+ 融合组的Gn 用药天数、Gn 用量均低于其他3 组(Gn 用药天数的 t 值分别为4.454、3.836、3.737,Gn 用量的t 值分别为2.328、2.490、2.779 ,P 值均<0.05);8C+7C 组、8C+8C 组、8C+9C 组间的Gn 用药天数、Gn 用量比较,差异无统计学意义(P 值均>0.05)。8C+7C 组、8C+8C 组、8C+9C 组、8C+ 融合组的临床妊娠率分别为58.6%(34/58)、55.3%(99/179)、44.4%(16/36)、76.9%(20/26),活产率分别为46.6%(27/58)、48.6%(87/179)、38.9%(14/36)、69.2%(18/26);8C+ 融合组的临床妊娠率和活产率均高于8C+8C 组、8C+9C 组(临床妊娠率的χ2 值分别为4.356、6.540,活产率的χ2 值分别为3.866、5.565,P 值均<0.05);8C+ 融合组与8C+8C 组、8C+9C 组的种植率、流产率比较,差异无统计学意义(P 值均>0.05);其他各组间的临床妊娠率、种植率、流产率和活产率比较,差异均无统计学意义(P 值均>0.05)。 结论 ICSI 第3 天新鲜移植周期中,减少Gn 用药天数和用量,可获得更多的融合期胚胎,并且融合期胚胎的发育潜能高于卵裂期胚胎,有更好的妊娠结局。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  卵胞浆内单精子显微注射  促性腺激素  体外受精- 胚胎移植  融合期胚胎  临床妊娠率  活产率  妊娠结局    
Abstract: 【Abstract】 Objective To investigate the correlation of gonadotropin (Gn) medication days and total
Gn dosage with embryonic development potential on the third day of fresh transplantation cycles with
intracytoplasmic sperm injection (ICSI), and the effect of embryo development speed on pregnancy
outcomes. Method A retrospective analysis was performed in patients who received ICSI in the the
First Affiliated Hospital of Navy Medical University, from January 1, 2017 to December 31, 2020. A total
of 299 cycles of in vitro fertilization - embryo transfer (IVF-ET) on the third day of embryo development
were included. According to the number of blastomes, they were divided into 8-cell (8C) +7-cell (7C) group,8C+8C group, 8C+9C group and 8C+ early fusion group (including partial fusion embryos and fusion
embryos). Embryo cleavage was observed in the morning of day 0 (D0) and day 3 (D3), that is, 67-69 h
after fertilization, and two embryos were transferred. The woman's age, body mass index (BMI), folliclestimulatinghormone (FSH), years of infertility, days of Gn medication, Gn, number of eggs obtained in a cycle, number of embryos transferred, implantation rate, abortion rate, clinical pregnancy rate and live birth rate were recorded. One-way analysis of variance and χ2 test were used for statistical analysis. Result There were no statistical differences in age, BMI, years of infertility and FSH among all groups (all P>0.05). The days of Gn medication in 8C+7C group, 8C+8C group, 8C+9C group and 8C+ fusion group were(10.9±2.8), (10.3±2.2), (10.7±2.3) and (8.5±2.2) days, respectively. The dosage of Gn was (2 172±615), (2 167±673), (2 332±796), and (1 779±719) IU, respectively. The days of medication and dosage of Gn in 8C+fusion group were lower than those in the other three groups (t values of days of medication for Gn were 4.454, 3.836 and 3.737, and t values of dosage for Gn were 2.328, 2.490 and 2.779, respectively, all P<0.05). There were no statistical differences in the days of medication and dosage of Gn in 8C+7C group, 8C+8C group and 8C+9C group (all P>0.05). The clinical pregnancy rates of 8C+7C group, 8C+8C group, 8C+9C group and 8C+fusion group were 58.6% (34/58), 55.3% (99/179), 44.4% (16/36) and 76.9% (20/26), respectively. The live birth rates were 46.6% (27/58), 48.6% (87/179), 38.9% (14/36) and 69.2% (18/26), respectively. The clinical pregnancy rate and live birth rate in 8C+fusion group were higher than those in8C+8C and 8C+9C groups (χ2 values of clinical pregnancy rate were 4.356 and 6.540, and χ2 values of the live birth rate were 3.866 and 5.565, respectively, P<0.05). There were no significant differences in the implantation rate and abortion rate among 8C+fusion group, 8C+8C group and 8C+9C group (all P>0.05). There were no statistical differences in implantation rate, live birth rate, clinical pregnancy rate and abortion rate among other groups (all P>0.05). Conclusion On the third day of ICSI fresh transfer cycles, more fusion embryos could be obtained by reducing the days and dosage of Gn. The developmental potential of fusion embryos was higher than that of embryos in cleavage stage, with better pregnancy outcomes.
Key words:  Intracytoplasmic sperm injection    Gonadotropin    In vitro fertilization - embryo transfer    Fusion embryo    Clinical pregnancy rate    Live birth rate    Pregnancy outcome
收稿日期:  2021-12-22                出版日期:  2023-05-31      发布日期:  2023-05-31      期的出版日期:  2023-05-31
通讯作者:  颜宏利    E-mail:  13321805629@163.com
引用本文:    
胡婷婷 汪伟伟 胡益祥 张颖 蔡艳萍 颜宏利. 卵胞浆内单精子显微注射治疗周期中促性腺激素用药对胚胎发育潜能的影响[J]. 发育医学电子杂志, 2023, 11(3): 168-173.
Hu Tingting, Wang Weiwei, Hu Yixiang, et al. Effect of gonadotropin administration on embryonic developmental potential during intracytoplasmic sperm microinjection. Journal of Developmental Medicine(Electronic Version), 2023, 11(3): 168-173.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2023.03.002  或          http://www.fyyxzz.com/CN/Y2023/V11/I3/168
[1] 吴正沐 王正权 王旻 谈雅静 李文. 时差成像胚胎培养系统观察精子DNA碎片化指数对卵胞浆内单精子显微注射的胚胎发育及临床结局的影响[J]. 发育医学电子杂志, 2024, 12(2): 130-135.
[2] 李丹 杨小倩 曹雪萍. 贫血孕妇血清铁及可溶性血清转铁蛋白受体检测对妊娠结局的预测价值[J]. 发育医学电子杂志, 2024, 12(1): 30-35.
[3] 于怡清 周希亚 蒋宇林 吕嬿 常家祯 郝娜 李萌萌 戚庆炜. 16 例无创产前检测8 号染色体异常病例的产前诊断结果及妊娠结局分析[J]. 发育医学电子杂志, 2023, 11(5): 338-345.
[4] 曾贵红 邹伟洋 刘长娣 陈玉兰 温婷媚. 妊娠期特有并发症患者不同孕期脂代谢异质性及临床监测意义[J]. 发育医学电子杂志, 2023, 11(3): 174-180.
[5] 张娇 谭友慧 高静. 来曲唑递增方案诱导排卵在多囊卵巢综合征患者中的临床效果[J]. 发育医学电子杂志, 2023, 11(1): 7-13.
[6] 焦婷婷 李建华 张水文 王建业 魏岩.
促性腺激素释放激素激动剂预处理时间对子宫腺肌病合并不孕症患者妊娠结局的影响
[J]. 发育医学电子杂志, 2022, 10(6): 417-422.
[7] 朱元昌 袁琳 谭芳 马壮鸿 邓伟芬. 低比例多原核受精对胚胎发育参数和临床妊娠结局的影响[J]. 发育医学电子杂志, 2022, 10(5): 346-352.
[8] 邹旷妮 姜春蓉 张素蓉. 孕中期子宫动脉多普勒超声血流参数联合血清学指标预测不良妊娠结局的价值[J]. 发育医学电子杂志, 2022, 10(3): 189-195.
[9] 房爱素 王秀芹. 血清游离β- 人绒毛膜促性腺激素和妊娠相关蛋白-A 与胎儿生长受限的相关性分析[J]. 发育医学电子杂志, 2021, 9(6): 432-436.
[10] 纪逸萱 王亮 郝敏 刘延 李招娣 李文. 卵胞浆内单精子显微注射技术周期中胚胎质量的影响因素及预测模型[J]. 发育医学电子杂志, 2021, 9(5): 335-340.
[11] 卢雪景 梁建梅 申林林 白娅琴 秦丽欣 高金霞 王亚凡. 低分子肝素联合小剂量阿司匹林对复发性流产患者血栓前状态、肝功能及免疫功能的影响[J]. 发育医学电子杂志, 2021, 9(3): 214-219.
[12] 康诠敏 金帆. 卵巢储备功能的影响因素及评估方法#br#[J]. 发育医学电子杂志, 2021, 9(2): 81-86.
[13] 蒋忠新 李文. 早发性卵巢功能不全的生殖治疗现状与展望[J]. 发育医学电子杂志, 2020, 8(2): 99-105.
[14] 汪翔 孙宁霞 王亮 郝敏 庞文娟 封旭 纪逸萱 李文. 血清维生素D 水平对卵巢功能减退患者体外受精- 胚胎移植助孕结局的影响[J]. 发育医学电子杂志, 2020, 8(2): 115-121.
[15] 刘娜 王硕. 妊娠合并巨大子宫肌瘤的临床特点及围产结局[J]. 发育医学电子杂志, 2020, 8(1): 42-46.
[1] Society of Neonatologist, Chinese Medical Doctor Association. Consensus recommendations on the prevention and early management of respiratory distress syndrome in preterm infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 129 -131 .
[2] Professional Committee of Respiratory, Society of Neonatologist, Chinese Medical Doctor Association. Clinical application recommendations for heated humidified high flow nasal cannula[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 132 -135 .
[3] YAN Jun, ZHU Xing-wang, SHI Yuan. Application progress of noninvasive ventilate technique for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 136 -140 .
[4] GU Min-fang, YANG Chuan-zhong. Progress of intrapartum resuscitation for premature infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 141 -145 .
[5] LIU Shu-hua, SHEN Yue-bo, LIU Cui-qing, MA Li. The efficacy of pulmonary surfactant for pulmonary function in premature tension pneumothorax[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 146 -151 .
[6] GAO Xiao-hui, MAO Jian. Clinical features of non-oliguric hyperkalemia in extremely low birth weight infants[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 152 -158 .
[7] XIA Yao-fang, YANG Juan , TIAN Bao-li, et al. Value of amplitude-integrated electroencephalography in monitoring acute period of neonatal bilirubin encephalopathy and prognostic assessment[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 159 -163 .
[8] WANG Li-rong, SUN Xiao-yan, ZHU Ruo-xin, et al. Epidemiological investigation and analysis of women aged 40-55 years old with osteoporosis in Gansu province[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 164 -167 .
[9] CHEN Ru-yue, SHEN Yun-yan, CHEN Qing , et al. Five cases about Henoch-Schönlein purpura complicated with central nervous system injury in children and literatures review[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 168 -171 .
[10] ZHANG Ai-run, FANG Xiao-yi. Lung function testing of bronchopulmonary dysplasia for infants and children[J]. Journal of Developmental Medicine(Electronic Version), 2017, 5(3): 172 -176 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed